Citadel Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $164K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $87K | Buy |
|
|||||
|
2019
Q2 | $100K | Sell |
|
|||||
|
2019
Q1 | $2.2M | Sell |
|
|||||
|
2018
Q4 | $6.63M | Sell |
|
|||||
|
2018
Q3 | $10.3M | Buy |
|
|||||
|
2018
Q2 | $1.1M | Buy |
|
|||||
|
2018
Q1 | $781K | Buy |
|
|||||
|
2017
Q4 | $419K | Buy |
|
|||||
|
2017
Q3 | $172K | Sell |
|
|||||
|
2017
Q2 | $347K | Sell |
|
|||||
|
2017
Q1 | $1.24M | Buy |
|
|||||
|
2016
Q4 | $170K | Sell |
|
|||||
|
2016
Q3 | $751K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $100K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $507K | Buy |
|
|||||
|
2015
Q2 | $532K | Buy |
|
|||||
|
2015
Q1 | $230K | Sell |
|
|||||
|
2014
Q4 | $1.19M | Buy |
|
|||||
|
2014
Q3 | $162K | Buy |
|
|||||
|
2014
Q2 | $31K | Sell |
|
|||||
|
2014
Q1 | $68K | Sell |
|
|||||
|
2013
Q4 | $512K | Sell |
|
|||||
|
2013
Q3 | $778K | Sell |
|
|||||
|
2013
Q2 | $1.77M | Buy |
|